Clinical Trials Directory

Trials / Unknown

UnknownNCT02989883

Clinical Outcomes of Peroral Endoscopic Myotomy

Clinical Outcomes of Peroral Endoscopic Myotomy for Esophageal Outflow Obstruction

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Asan Medical Center · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Esophageal outflow obstruction is characterized by failure to relax the lower esophageal sphincter (LES), resulting in impaired flow of ingested food into the stomach. The subsequent stasis of ingested food leads to symptoms of dysphagia, regurgitation, chest pain, and weight loss. The core objective of the treatment of esophageal outflow obstruction is to disrupt the LES and reduce its pressure to allow esophageal emptying. Therapeutic options include pharmacologic therapy, Botulinum toxin injection, pneumatic balloon dilation, and surgical myotomy with partial fundoplication. In addition, peroral endoscopy myotomy (POEM) has recently been introduced as a minimally invasive treatment, but there have a few studies regarding long-term outcomes. The aim of this study is to evaluate clinical outcomes of POEM for esophageal outflow obstruction.

Detailed description

Prospective study

Conditions

Interventions

TypeNameDescription
OTHERperoral endoscopic myotomyThe procedure consists of four steps: 1) mucosal incision 10-15 cm above the esophagogastric junction to allow entry into the submucosa, 2) creation of a submucosal tunnel until the lower esophageal sphincter is reached, 3) myotomy of the circular muscle layer, and 4) closure of the mucosal entry with endoclips.

Timeline

Start date
2016-10-01
Primary completion
2018-03-01
Completion
2018-09-01
First posted
2016-12-12
Last updated
2016-12-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02989883. Inclusion in this directory is not an endorsement.